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Abstract
Background: Insulin stimulates exocytosis of GLUT4 from an intracellular store to the cell surface of fat and muscle
cells. Fusion of GLUT4-containing vesicles with the plasma membrane requires the SNARE proteins Syntaxin 4,
VAMP2 and the regulatory Sec1/Munc18 protein, Munc18c. Syntaxin 4 and Munc18c form a complex that is
disrupted upon insulin treatment of adipocytes. Munc18c is tyrosine phosphorylated in response to insulin in these
cells. Here, we directly test the hypothesis that tyrosine phosphorylation of Munc18c is responsible for the
observed insulin-dependent abrogation of binding between Munc18c and Syntaxin 4.
Results: We show that Munc18c is directly phosphorylated by recombinant insulin receptor tyrosine kinase in vitro.
Using pull-down assays, we show that phosphorylation abrogates binding of Munc18c to both Syntaxin 4 and the
v-SNARE VAMP2, as does the introduction of a phosphomimetic mutation into Munc18c (Y521E).
Conclusion: Our data indicate that insulin-stimulated tyrosine phosphorylation of Munc18c impairs the ability of
Munc18c to bind its cognate SNARE proteins, and may therefore represent a regulatory step in GLUT4 traffic.
Background
Insulin stimulates glucose transport into fat and muscle
by regulating translocation of the facilitative glucose
transporter GLUT4 from an intracellular store to the
plasma membrane (PM) [1]. In the absence of insulin,
~95% of cellular GLUT4 is sequestered within intracellu-
lar compartment(s), including specialised GLUT4 storage
vesicles (GSVs)[1]. Upon insulin stimulation, GSVs traffic
to the PM, resulting in a 10- to 20-fold increase in PM
G L U T 4l e v e l s[ 1 ] .T h i si sa c h i e v e db ya ni n c r e a s ei nt h e
rate of exocytosis and an inhibition of endocytosis [2].
GLUT4 is transported between various intracellular
membrane-bound compartments by vesicular transport.
Membrane traffic in all eukaryotic cells is controlled by
specific SNARE complexes [3]. Members of the t-(tar-
get) family of SNARE proteins mark specific organelles.
The formation of complexes between t-SNAREs and
their cognate v-(vesicle) SNARE localised to the appro-
priate donor membrane is sufficient to catalyse bilayer
fusion [4], thus SNAREs have been proposed to impart
specificity to membrane traffic [3]. The t-SNARE com-
plex consisting of Syntaxin4 and SNAP-23 (Sx4/S-23)
controls fusion of GLUT4-containing vesicles with the
PM, resulting in the final delivery of the transporter to
the PM in response to insulin [1]. The predominant v-
SNARE involved in this step is VAMP2 [1].
All SNARE complexes are subject to strict regulation
to ensure that the trafficking steps they catalyse take
place within the correct spatial and temporal coordi-
nates. The Sec1/Munc18 (SM) family of proteins are key
regulators of syntaxin function [5]. The SM protein that
binds to Sx4 is Munc18c [1]. Adipocytes derived from
MEFs from Munc18c knockout mice show enhanced
GLUT4 translocation, suggesting that Munc18c inhibits
insulin-stimulated externalization of GLUT4. This sug-
gests that disruption of interaction between Sx4 and
Munc18c might result in enhancement of insulin-stimu-
lated GLUT4 translocation [6]. Consistent with this,
over-expression of Munc18c was found to inhibit insu-
lin-stimulated GLUT4 translocation in 3T3-L1 adipo-
cytes, as did peptides designed to inhibit the binding of
Munc18c to Sx4 [7,8]. Interestingly, Munc18c was
found to inhibit the fusion of artificial liposomes
mediated by Sx4/S-23 and VAMP2 in vitro [9], further
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GLUT4 vesicles with the PM.
How may negative regulation of Sx4 by Munc18c be
alleviated upon insulin treatment? Like many syntaxins,
Sx4 adopts two distinct conformations, a closed confor-
mer with the Habc domain folded back onto the SNARE
domain (thus rendering this molecule unable to form
functional SNARE complexes) and an open conforma-
tion with the Habc domain moved away from the
SNARE domain. SM proteins have been shown to bind
both of these conformations [10]: in mode 1, the central
cavity of arch-shaped SM proteins cradle their cognate
syntaxin in a closed conformation; in mode 2 the open
conformation of syntaxin generates a free N-terminus
which inserts into a hydrophobic pocket on the opposite
face of the SM protein. Furthermore, it is now estab-
lished that SM proteins can bind to their cognate
SNARE ternary complex via a distinct mode (mode 3
binding), and it has been suggested that this mode of
interaction between SM proteins and the SNARE
machinery is of considerable importance [11,12]. Using
an in vitro assay of fusion, the interaction of the SM
protein Munc18a with its cognate SNARE complex
accelerates fusion, with the SM protein making contact
with both the t- and v-SNAREs [13]. By contrast, in the
same kind of assay, Munc18c appears to act as an inhi-
bitor of fusion [9]. Such data suggest the possibility that
insulin may modulate one these binding modes between
Sx4 and Munc18c to modulate fusion, but how this may
be achieved is unknown.
Munc18c is known to become tyrosine phosphorylated
(on Tyr-521) upon insulin stimulation of 3T3-L1 adipo-
cytes [14], but whether Munc18c is a direct target of the
insulin receptor tyrosine kinase or whether another
kinase(s) is(are) responsible is unknown. Studies in b-
cell lines have suggested phosphorylation of Munc18c
may be a crucial trigger for insulin granule fusion with
the PM [15]. Stimulation of 3T3-L1 adipocytes with
insulin or platelet-derived growth factor (PDGF) pro-
motes tyrosine phosphorylation of Munc18c, a modifica-
tion that occurs concomitant with an observed
dissociation of the Sx-4/Munc18c complex [16]. Expres-
sion of a mutant form of Munc18c (Y521A) was found
to inhibit PDGF-stimulated GLUT4 translocation, sug-
gesting that the tyrosine phosphorylation of Munc18c
may impact the trafficking machinery involved in
GLUT4 mobilisation. However, the effect of the Y521A
mutant on insulin-stimulated GLUT4 trafficking
remains unclear, since over-expression of both wild-type
or mutant forms of Munc18c both inhibited GLUT4
translocation [16]. Although this latter study reveals that
the Sx4/Munc18c complex is dissociated concomitant
with tyrosine phosphorylation of Munc18c, whether this
is a direct effect of tyrosine phosphorylation of
Munc18c was not addressed, and little is known regard-
ing the consequences of tyrosine phosphorylation on the
ability of Munc18c to bind Sx4. To address this, we
have used an in vitro approach to study the conse-
quence of Munc18c phosphorylation on its binding to
Sx4. We show that Munc18c is directly phosphorylated
in vitro by recombinant insulin receptor tyrosine kinase,
and that this phosphorylation occurs only on residue
521. Once phosphorylated, Munc18c is no longer able
to bind monomeric Sx4 by either mode 1 or mode 2.
Similarly, a phospho-mimetic mutant of Munc18c,
Y521E, is unable to bind to either Sx4 or VAMP2.
These data suggest that the tyrosine phosphorylation of
Munc18c in response to insulin may trigger dissociation
of Munc18c from Sx4, thus facilitating the formation of
a SNARE complex for vesicle fusion.
Results and Discussion
Munc18c is directly phosphorylated by the insulin
receptor in vitro
A proteomics based screen of insulin-stimulated tyrosine
phosphorylated proteins in 3T3-L1 adipocytes revealed
that Munc18c exhibits a >10-fold increase in tyrosine
phosphorylation on residue 521 [14]. As this screen did
not inform on the extent of tyrosine phosphorylation of
any identified target nor reveal whether the kinase
response was the insulin receptor itself, we sought to
determine whether the insulin receptor can directly
phosphorylate Munc18c and if so, to what extent. To
address this, we employed a recombinant protein corre-
sponding to residues 941-1343 of the b-subunit of the
insulin receptor, the region containing the tyrosine
kinase domain (referred to as Cytosolic Insulin Receptor
K i n a s e ,C I R K )[ 1 7 ] .T h i sp r o t e i n ,w h e ne x p r e s s e da n d
purified from baculovirus-infected Sf9 cells, mimics at
least some of the reactions catalysed by the insulin
receptor itself [17,18]. Using an in vitro kinase assay, we
found that CIRK phosphorylates recombinant Munc18c
in a time- and dose-dependent manner, such that by
150 minutes ~30% of the Munc18c in the reaction was
phosphorylated (Figure 1). We next determined which
residue(s) of Munc18c are phosphorylated by CIRK in
vitro by subjecting the samples to mass spectrometry
(Additional file 1). This revealed that the only residue of
Munc18c phosphorylated by CIRK was Tyrosine-521
(Figure 1), unequivocally demonstrating that, at least in
vitro, Munc18c is a direct target of the insulin receptor.
Phosphorylation of Munc18c abrogates binding to
syntaxin 4 and VAMP2
Munc18c binds both the open and closed conformations
of Sx4, as well as to the v-SNARE, VAMP2 [19]. We
therefore sought to determine whether phosphorylation
of Munc18c modulates these interactions. Four different
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Sepharose were employed [19]: wild-type Sx4, Sx4-open
(a L173A/E174A mutant of Sx4 which adopts an open
conformation), Sx4 lacking the N-terminal 36 amino
acids (required for mode 2 binding to Munc18c; N36Δ)
and a double mutant (open plus N36Δ). These were
incubated with Munc18c pre-incubated with or without
CIRK (Figure 2A). After incubation, the amount of
Munc18c associated with the Sx4-proteins was deter-
mined by immunoblotting. Figure 2A shows that
Munc18c was readily detected in complex with the
wild-type GST-Sx4 and the ‘open’ mutant, but was dra-
matically reduced for the N36Δ and double mutants, in
agreement with previous studies [19]. Following pre-
incubation with CIRK, a reduction in the amount of
Munc18c in complex with the Sx4 species was evident
(Figure 2A, quantified in Figure 2B).
In order to ascertain whether this reduction is a con-
sequence of tyrosine phosphorylation of Munc18c, we
performed immunoblot analysis using anti-phosphotyro-
sine antibodies (Figure 2C). This revealed that none of
the tyrosine phosphorylated Munc18c was in association
with any of the GST-Sx4 species examined. Under the
conditions employed, CIRK treatment resulted in tyro-
sine phosphorylation of ~30% of the input Munc18c.
Given that tyrosine phosphorylated Munc18c cannot
b i n dS x 4( F i g u r e2 C )t h i se x p l a i n sw h yt h el e v e l so f
Munc18c in association with Sx4, detected by anti-
Munc18c, are reduced upon CIRK treatment by ~30%, a
figure in close agreement with the extent of Munc18c
phosphorylation observed under these conditions
(Figure 2A, quantified in Figure 2B).
We have previously reported that Munc18c binds the
v-SNARE VAMP2 [19]. We therefore examined whether
this interaction is modulated by Munc18c tyrosine phos-
phorylation (Figure 3). Although Munc18c readily
bound GST-VAMP2, none of the pulled-down protein
was immuno-reactive with anti-phosphotyrosine antibo-
dies. Collectively, our data suggest that Munc18c is
unable to interact with either its cognate syntaxin (Sx4)
or VAMP2 when phosphorylated on Y521.
A phosphomimetic mutant of Munc18c is unable to bind
Syntaxin 4 or VAMP2
To substantiate these findings, we made a mutant of
Munc18c with Y521 replaced by the (relatively) bulky
negative residue glutamate (Y521E); although not aro-
matic, the side chain of glutamate is the biggest of the
negatively charged amino acids and thus we hoped would
function as a phosphomimetic. The characteristics of this
protein were examined. The mutant was recognised by
anti-Munc18c and exhibited the expected molecular
weight (Figure 4A). The wild-type and mutant proteins
exhibited similar far UV circular dichroism spectra, sug-
gesting that Munc18c-Y521E exhibited little change in
overall secondary structure compared to the wild-type
protein, a conclusion further supported by the similar
intrinsic tryptophan fluorescence spectra of the two pro-
teins (data not shown). We therefore repeated the bind-
ing studies of Figure 2, this time using Munc18c-Y521E
or wild-type Munc18c. As shown in Figure 4, we were
unable to detect any binding of Munc18c-Y521E to Sx4
(or VAMP2, data not shown). In experiments not shown,
we were unable to detect any interaction between
Munc18c-Y521E and Sx4 even with a ~50-fold excess of
Munc18c over Sx4 (see legend to Figure 4), or when
recombinant Munc18c-Y521E was immobilised to Ni-
Agarose and incubated with recombinant Sx4.
These data support the notion that phosphorylation of
Munc18c on Y521 may represent an insulin-controlled
regulatory mechanism. Although the structure of
Munc18c has been largely solved [20], Y521 is in an
unstructured area, probablyaf l e x i b l ed o m a i n ,l o c a t e d
near the surface of the molecule. The structure reveals
that Y521 is close to the hydrophobic pocket into which
t h eN - t e r m i n u so fS x 4i n s e r t si nm o d e2b i n d i n g[ 2 0 ] .
However, this would not explain why CIRK-phosphory-
lated Munc18c or Munc18c-Y521E do not bind either
closed Sx4 or VAMP2. It is possible that the phosphory-
lation of Y521 may cause a more significant structure
change in Munc18c, abrogating all binding modes, but
CD and fluorescence analysis of the mutant suggests this
is unlikely. Regardless, our data suggest that Y521 phos-
phorylation of Munc18c abrogates binding to monomeric
Figure 1 Munc18c is a substrate for CIRK in vitro. A 1 μg
Munc18c was incubated with or without 370 ng CIRK in the
presence of [g-32P]-ATP. Reactions were stopped by boiling in
Laemmli buffer prior to SDS-PAGE/autoradiography. Shown are data
from a representative experiment. B 1 μg Munc18c was incubated
with 370 ng CIRK in the presence of [g-
32P]-ATP for 30 minutes (lane
1), 120 minutes (lane 2), or 150 minutes with 1.8 μg CIRK (lane 3).
Reactions were stopped as in A. Note that different exposures of
the autoradiograms are shown for clarity. C Two phosphopeptides
were identified by Mass Spec analysis of phosphorylated Munc18c
(peptide 2 represents mis-cleavage of peptide 1).
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mulated SNARE-mediated delivery of GLUT4 to the PM.
Studies in which this mutant of Munc18c is expressed in
adipocytes at levels similar to wild-type protein in the
absence of the endogenous Munc18c will be important.
At present, such studies are proving technically challen-
ging, as over-expression of even wild-type Munc18c sig-
nificantly impairs GLUT4 translocation [8]. Given our
incomplete understanding of the functional role played
by the different modes of Munc18 binding, a future
assessment of the consequences of Munc18c phosphory-
lation on mode 3 binding to its cognate SNARE ternary
complex will be informative.
Conclusions
The data presented support the hypothesis that Y521
phosphorylation of Munc18c by the insulin receptor tyr-
osine kinase abrogates binding to monomeric Sx4 and
V A M P 2 ,s u g g e s t i n gt h a tt h i se v e n tm a yp l a yar o l ei n
insulin-stimulated SNARE-mediated delivery of GLUT4
to the PM.
Methods
Recombinant protein expression
pQE30-Munc18c was used as template for the Y521E-
coding mutant which was fully sequenced on both
strands. His-6-Munc18c and His-6-Munc18c-Y521E
Figure 2 Munc18c phosphorylated by CIRK no longer binds Sx4. A 1 μg of GST, Sx4-GST or the Sx4 mutants immobilised on glutathione-
Sepharose were incubated with 1 μg of Munc18c (previously treated with or without 370 ng CIRK for 150min) in binding buffer overnight at 4°C.
6% of the samples were removed and subjected to SDS-PAGE and Coomassie stained to assess inputs (upper panels). Sepharose beads were
washed prior to immunoblot analysis with anti-Munc18c (10% of eluted material; lower panels). Data shown are from representative experiments,
repeated three times with similar results. B Shows quantification of the data from 3 experiments of this type. Levels of control (non-
phosphorylated) Munc18c bound to the different Sx4 species is expressed as a % of the level bound to wild-type Sx4 (black bars), (mean ± SD).
Data from phosphorylated Munc18c (grey bars) is also shown. Note that the level of binding of phosphorylated Munc18c to wild-type Sx4 is
decreased by ~30%. Quantification of the extent of phosphorylation of Munc18c under these conditions revealed that a roughly equivalent fraction
of Munc18c is phosphorylated. See text for details. The amount of Munc18c captured by the different Sx4 species is in good agreement with
published data [19]. C The material eluted from the beads was also probed with anti-phosphotyrosine antibodies (40% of eluted material loaded
per lane) as labelled. In this case, the indicated amounts of input were also loaded in order to confirm the presence or absence of any tyrosine
phosphorylated Munc18c in the GST pull-down. Data shown are from representative experiments, repeated three times with similar results.
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Ni-NTA-agarose as described [9]. The recombinant
Sx4 species and GST-VAMP2 were expressed and pur-
ified as reported [9,19]. Note that the Sx4-GST fusions
employed in this study encompass the entire cytosolic
domain of the Sx4 (residues 1-273) with the GST
added at the C-terminus of the Sx4. As we have pre-
viously reported, in this construct, the GST-moiety
does not interfere with binding of Munc18c [19]. The
Sx4-open mutant and the other mutants were those
characterised in [19].
Pull-down assays
1 μg GST-Sx4 (or mutants thereof), immobilised on
glutathione-Sepharose, was incubated overnight with 1
μg recombinant Munc18c (pre-treated with or without
cytosolic insulin receptor kinase) or 1 μg recombinant
Munc18c-Y521E in 300 μl of binding buffer (20 mM
Hepes pH 7.4, 150 mM potassium acetate, 1 mM
MgCl2 and 0.05% (v/v) Tween-20) at 4°C with rotation
[19]. After removal of a sample to assess input levels,
unbound protein was removed by three washes in
binding buffer, followed by three washes in binding
buffer containing 0.2% (w/v) fish tail gelatin, three
washes in binding buffer containing 5% (w/v) glycerol
and three washes in binding buffer alone. Beads were
resuspended in Laemmli sample buffer, boiled for 5
minutes and bound proteins by SDS-PAGE and/or
immunoblotting.
CIRK phosphorylation assays
Recombinant CIRK [17] was provided by Professor
Gustav E. Lienhard (Dartmouth Medical School). 1 ml
recombinant CIRK (8 mg/ml) was activated by incuba-
tion with an equal volume of 100 mM Hepes pH 7.5,
4m Ms o d i u mA T P ,5m MM n C l 2 and incubated at
30°C for 30 minutes. CIRK was then diluted 10-fold
into 50 mM Hepes pH 7.5 containing 10% (v/v) gly-
cerol and 1 mM dithiotheritol [17]. At this stage,
CIRK was at 0.4 mg/ml and the specific activity was
assayed to be 46 nmol/min/mg. Samples were stored
at -80°C with no loss of activity over the periods of
these experiments.
For in vitro kinase assays, CIRK was mixed with
Munc18c (1 μg) in 50 μl kinase buffer (50 mM Hepes
pH 7.5, 4 mM MnCl2,0 . 2m MD T Ta n d1 0 0μMN a -
ATP), and incubated at 30°C for the times indicated.
In some experiments, this was supplemented with 6
μCi [g-
32P]-ATP to allow the stoichiometry of phos-
phorylation to be determined. Monoclonal anti-phos-
photyrosine antibodies (PT-66) were from AbCam
(Cambridge, UK).
Mass spectrometry
Analysis of the sites of phosphorylation of Munc18c by
C I R Kw a sp e r f o r m e da tt h eD u n d e eU n i v e r s i t yP o s t -
Genomics Facility. After incubation of 1 μg Munc18c
with CIRK for 30 minutes at 30°C, the sample was tryp-
sinised and the phosphorylated sites determined by
liquid chromatography-electrospray ionisation-mass
spectrometry (LC-ESI-MS) using an ABI QTrap 4000
instrument. This generated two major [M-2H]
2- (double
charged) quase molecular ions at m/z 551.3 and 615.3
which were absent from the control Munc18c sample
that was not incubated with CIRK, suggesting that they
represent phosphorylated tryptic peptides. After identifi-
cation, the same ions were submitted to ESI-MS/MS to
determine their amino acid sequence and to locate the
phosphorylated residue.
Figure 3 Munc18c phosphorylated by CIRK no longer binds
VAMP2.1μg of GST or GST-VAMP2 immobilised on glutathione-
Sepharose were incubated with 1 μg of Munc18c (which had been
previously treated with or without 1.8 μg CIRK for 150min) in
binding buffer overnight at 4°C. Sepharose beads were washed
prior to immunoblot analysis with anti-Munc18c (upper panel) or
anti-phosphotyrosine antibodies (lower panel) as labelled. In the
case of the anti-phosphotyrosine immunoblot, the indicated
amounts of input were also loaded to reveal the presence or
absence of any tyrosine phosphorylated Munc18c in the GST pull-
down. Data shown are from representative experiments, repeated
three times with similar results.
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Additional file 1: Mass Spec analysis of phosphorylated Munc18c.
Upper panel:1μg of Munc18c was incubated with CIRK for 30 minutes
as described in materials and methods. The reaction was stopped, the
sample trypsinised and analysed by LC-ESI-MS in a Qtrap 400 in negative
ion mode. The spectrum shows only the ions detected by the precursor
ion scan of 79 mass units which represents PO3
- and suggest a
phosphopeptide. The insert shows a detail of the two major [M-2H]
2-
ions (peptide 1 and 2). The peptides are accompanied by the same
peptide coupled to one or two metal ions (i.e. m/z 562.3, 569.3 and
580.3 for peptide 1 and 625.3, 633.3 and 644.4 for peptide 2). Lower
panel: Exactly as upper panel except Munc18c was incubated in CIRK
buffer for 30 minutes in the absence of CIRK (i.e. non-phosphorylated
control).
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